QA: Equillium Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001746466_2023_Equillium_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001746466, Equillium Inc

  xvar xval
0 AssetsCurrent 76,735,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 391,000
3 remainder_Assets 1,295,000
4 LiabilitiesCurrent 32,038,000
5 LiabilitiesNoncurrent 824,000
6 remainder_Liabilities 13,617,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 30,748,547
9 ResearchAndDevelopmentExpense 62,072,691
10 remainder_Expenses 23,049,000
11 remainder_Revenues 15,759,000
12 remainder_NetIncome -718,001
13 remainder_ComprehensiveNetIncome 198,039
  yvar yval
0 Assets 78,421,000
1 Liabilities 46,479,000
2 Expenses 115,870,238
3 Revenues 15,759,000
4 StockholdersEquity 31,942,000
5 NetIncome -100,829,239
6 ComprehensiveNetIncome -100,730,220
7 BaseVar 128,722,639
8 EconomicCapitalRatiobeforeLimitedLiability -0.498
9 EconomicCapitalRatio 1.38

Edgar->Model Mapping

Feature Distribution

Change over Time